Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Purple Biotech American Depositary Shares Representing 200 Ord Shs PPBT

Healthcare
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi... see more

Recent & Breaking News (NDAQ:PPBT)

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Kitov Pharmaceutical Holdings Ltd. - KTOV

PR Newswire March 28, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Kitov Pharmaceuticals Holdings LTD and Encourages Investors with Losses to Contact the Firm

Business Wire March 27, 2017

TyrNovo, a Kitov company, to Present Preclinical Data at the American Association for Cancer Research Annual Meeting

PR Newswire March 27, 2017

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Kitov Pharmaceuticals Holdings LTD To Contact The Firm

GlobeNewswire March 24, 2017

Lifshitz & Miller LLP Announces Investigation of Cemtrex, Inc., Kitov Pharmaceuticals Holdings LTD, NantHealth, Inc., Omega Protein Corporation, Pearson plc, Trecora Resources, Trivago N.V. and WPP plc

PR Newswire March 24, 2017

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Kitov Pharmaceuticals Holdings Ltd. To Contact The Firm

Business Wire March 14, 2017

ALERT: Rosen Law Firm Reminds Kitov Pharmaceutical Holdings Ltd. Investors of Important Deadline in Class Action - KTOV

GlobeNewswire March 13, 2017

Cohen Milstein Sellers & Toll PLLC Announces Investigation of Kitov Pharmaceuticals Holdings Ltd.

Business Wire March 10, 2017

Kitov Announces License Agreement for KIT-302 in South Korea

PR Newswire March 8, 2017

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Kitov Pharmaceuticals Holdings Ltd. (KTOV) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

GlobeNewswire March 3, 2017

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Kitov Pharmaceuticals Holdings LTD (KTOV) & Lead Plaintiff Deadline: April 10, 2017

GlobeNewswire March 2, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Kitov Pharmaceutical Holdings Ltd. - KTOV

GlobeNewswire February 27, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kitov Pharmaceuticals Holdings Ltd. of Class Action Lawsuit and Upcoming Deadline – KTOV

GlobeNewswire February 24, 2017

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Kitov Pharmaceuticals Holdings Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire February 21, 2017

KTOV STOCK DROP NOTICE: Rosen Law Firm Reminds Kitov Pharmaceutical Holdings Ltd. Investors of Important Deadline in Class Action - KTOV

Business Wire February 13, 2017

Robbins Arroyo LLP: Kitov Pharmaceuticals Holdings Ltd. (KTOV) Misled Shareholders According to a Recently Filed Class Action

Business Wire February 13, 2017

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Kitov Pharmaceutical Holdings LTD Investors and Encourages Investors to Contact the Firm

Business Wire February 13, 2017

IMPORTANT NOTICE TO SHAREHOLDERS: Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Kitov Pharmaceuticals Holdings Ltd. (KTOV) To Contact Brower Piven Be

GlobeNewswire February 11, 2017

Kitov Announces Settlement Agreement with Minority Shareholder of Recently Acquired TyrNovo

GlobeNewswire February 10, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Kitov Pharmaceuticals Holdings LTD (KTOV) & Lead Plaintiff Deadline: April 10, 2017

GlobeNewswire February 10, 2017